rfhg_100878.1

Basic information about the TSS

---

TSS ID: rfhg_100878.1 Species: human Chr: chr7		Start: 139571646 End: 139571648 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC043184:-209 GeneID: 28996 HGNC/MGI_ID: HGNC:14402 UniProt_ID: Nearer transcript ids and distances:

Gene_name: homeodomain interacting protein kinase 2 Gene_symbol: HIPK2 Gene_synonyms: Gene_source: HGNC:14402

TATA-Box annotation

---

Distance to TSS:	47962
Nearest PromoterID:	NM_001080511
Entrez ID:	154790
Nearest Unigene:	Hs.57806
Nearest Refseq:	NM_001080511
Nearest Ensembl:	ENSG00000236279
Gene Name:	homeodomain interacting protein kinase 2
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HIPK2 p2@HIPK2 p5@HIPK2 p6@HIPK2 p7@HIPK2 p8@HIPK2 p9@HIPK2 p10@HIPK2
Sample		p1@HIPK2	p2@HIPK2	p5@HIPK2	p6@HIPK2	p7@HIPK2	p8@HIPK2	p9@HIPK2	p10@HIPK2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.53	0.39	0.00	0.00	0.19	0.58	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.40	0.40	0.40	0.00	0.40	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.73	0.77	0.39	0.19	0.77	0.58	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.01	1.87	0.00	0.21	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.55	0.67	0.67	0.22	0.00	0.00	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	15.70	0.78	0.39	0.39	0.00	0.00	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.64	1.31	0.00	0.22	0.44	0.00	0.87	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.84	1.21	0.00	0.24	0.00	0.24	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.96	0.64	0.85	0.00	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	2.32	0.00	0.58	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.08	1.21	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.60	2.44	0.00	0.00	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.50	2.26	0.16	0.64	0.00	0.00	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.13	1.35	0.15	0.30	0.45	0.00	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.37	2.42	0.44	0.66	0.00	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.59	1.76	0.25	0.75	0.00	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.23	1.31	0.87	0.22	0.22	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.45	2.53	0.42	0.42	0.84	0.42	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	0.53	0.00	0.53	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.08	1.50	0.30	0.60	0.15	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	2.00	0.27	0.00	0.40	0.27	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.77	1.73	0.35	0.17	0.35	0.35	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.22	1.16	0.13	0.13	0.39	0.52	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.56	2.18	0.00	0.49	0.49	0.24	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.74	0.26	0.26	0.26	0.77	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.04	1.27	0.00	0.95	0.00	0.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	1.65	0.55	0.00	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.15	3.30	0.00	0.24	0.47	0.94	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.57	1.78	0.16	0.48	0.32	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.90	2.90	0.36	0.72	0.54	0.00	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.28	2.30	0.21	0.42	0.00	0.21	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.83	1.95	0.98	0.98	0.20	0.20	0.39	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.94	3.80	0.63	0.63	0.21	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.16	2.47	0.49	0.16	0.00	0.33	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.14	2.43	0.56	0.37	0.37	0.00	1.50	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.42	4.60	0.96	0.00	0.00	0.38	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.48	3.27	0.41	1.02	0.20	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.15	2.42	0.20	0.60	1.01	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.72	2.97	0.27	1.08	0.00	0.54	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.96	3.12	0.00	0.24	0.72	0.00	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.76	2.35	0.24	0.94	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.52	2.34	0.29	1.32	0.00	0.00	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.99	5.27	0.42	0.63	0.42	0.63	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.97	4.55	0.35	0.35	0.00	0.35	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.50	4.42	0.20	0.40	0.60	0.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.71	5.35	1.16	1.16	0.00	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.67	5.04	0.24	0.24	0.00	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.06	3.58	0.00	0.00	0.30	0.00	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.29	3.11	0.48	1.20	0.24	0.00	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.67	6.47	0.00	1.01	0.20	0.20	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.98	5.94	1.02	0.61	1.02	0.61	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.46	5.34	0.67	0.22	0.22	0.44	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.97	3.55	0.71	0.71	0.71	1.06	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	1.66	0.33	0.33	0.33	0.00	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	0.84	0.84	4.19	0.00	0.84	5.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	15.15	5.05	0.46	1.38	0.00	2.30	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.45	1.62	1.62	0.32	0.00	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.95	2.57	0.00	0.64	0.64	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.09	2.20	0.31	0.31	0.63	0.94	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	20.45	3.53	0.71	0.00	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	13.46	3.36	0.56	0.00	0.00	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	3.18	0.00	0.80	0.80	0.00	3.18	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.23	2.38	0.68	0.68	0.00	0.34	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	5.20	0.00	0.97	0.65	0.32	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.13	1.42	1.06	0.71	0.00	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.84	4.39	0.98	0.49	0.98	0.49	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	24.30	6.94	0.50	0.50	0.00	0.50	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	5.63	0.00	0.00	0.94	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.89	3.97	0.33	0.33	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.01	3.71	0.62	0.62	0.62	0.31	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.66	4.89	0.61	0.31	1.22	0.00	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	18.85	4.91	0.00	0.95	0.32	0.48	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	18.45	3.21	1.12	0.16	0.96	0.96	0.48	0.48
Adipocyte - omental, donor1	11473-119C6	14.63	4.96	0.38	0.89	0.51	0.25	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	14.95	0.00	0.00	1.49	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	12.73	2.01	0.33	0.33	0.00	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.02	2.55	0.00	0.64	0.00	0.64	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	38.84	2.26	0.00	0.00	0.00	0.00	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	24.50	2.78	0.52	0.70	0.17	0.00	0.87	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	19.36	2.93	0.39	1.17	0.20	0.00	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	20.08	3.60	0.51	0.00	0.26	0.00	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	14.50	3.90	0.28	0.00	0.56	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	19.40	2.94	0.59	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	27.35	5.63	0.40	0.08	0.00	0.24	0.24	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	17.75	1.94	0.32	0.65	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	1.60	0.53	0.00	0.53	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	4.45	0.00	0.00	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.88	4.16	0.00	0.42	0.00	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	12.06	1.76	0.00	0.25	0.00	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	5.89	0.00	0.00	0.33	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	23.14	5.18	0.00	0.00	0.00	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	15.47	2.21	0.22	0.22	0.00	0.22	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	10.04	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.03	4.50	0.36	0.18	0.18	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	6.69	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.42	5.55	0.41	0.62	0.41	0.00	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	38.68	2.52	0.69	1.49	0.00	0.57	0.92	0.23
Anulus Pulposus Cell, donor2	11463-119B5	50.70	4.41	0.98	1.47	0.00	1.71	1.22	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	1.35	0.45	0.00	0.45	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.51	2.60	0.43	0.43	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	6.42	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.28	0.90	0.60	0.30	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	0.00	0.66	0.66	0.66	0.66	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.52	1.95	0.32	0.32	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	3.88	0.00	0.97	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	1.78	0.00	0.59	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.03	1.51	0.38	0.00	0.00	1.13	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	2.18	2.18	0.73	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	2.51	0.00	1.25	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	1.48	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	1.36	0.00	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.43	1.36	0.15	0.60	0.00	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	2.14	0.00	0.54	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.48	1.70	0.76	0.19	0.00	0.19	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.55	1.87	0.53	0.80	0.53	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	4.88	0.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.98	1.33	0.17	0.00	0.00	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	1.20	0.00	1.20	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.58	3.95	0.17	0.51	0.00	0.17	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	3.88	1.46	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	3.79	0.76	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	2.85	0.00	0.57	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.34	1.07	0.00	0.21	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.42	2.06	0.52	0.52	0.26	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.63	1.88	1.88	0.00	0.00	0.47	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.82	2.25	1.29	0.32	0.32	0.32	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	0.00	0.00	1.43	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	0.58	0.00	0.00	0.58	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.82	1.20	0.30	0.60	0.00	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	0.00	0.00	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.56	0.00	0.51	0.00	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.11	0.51	0.25	0.00	0.00	0.51	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	1.27	0.00	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.61	0.43	0.86	0.43	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.77	0.85	0.00	0.42	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.35	1.45	0.00	0.58	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	2.83	1.89	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.76	1.19	0.00	0.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	0.00	0.00	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.72	0.43	0.00	0.86	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	0.60	0.00	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	2.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.36	2.30	0.00	0.00	0.23	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	5.10	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.85	2.29	0.00	0.25	0.25	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.84	2.27	0.00	0.00	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.20	0.61	0.00	0.00	0.31	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2.87	2.39	0.48	0.00	0.00	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	1.55	0.22	0.67	0.44	0.44	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.77	1.66	0.00	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.15	2.38	0.00	0.00	0.00	0.00	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.91	1.82	0.00	0.00	0.00	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	25.55	4.18	0.37	0.49	0.37	0.00	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	36.46	1.37	0.86	0.17	0.17	0.51	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	19.72	2.52	0.42	0.21	0.42	0.42	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	31.72	6.62	0.70	1.05	0.35	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	44.00	4.85	0.65	1.46	0.65	0.65	0.49	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	46.09	7.01	1.04	0.45	0.89	0.30	1.64	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	35.09	5.96	1.03	0.00	0.80	0.34	0.34	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	35.20	8.52	1.13	0.38	0.75	0.38	0.13	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	37.55	6.03	1.48	0.68	1.14	0.23	0.11	0.11
Basophils, donor1	12241-129G9	30.34	9.15	0.00	0.26	0.52	0.00	0.00	0.52
Basophils, donor2	12242-129H1	21.29	11.18	0.36	0.36	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	28.37	12.64	0.29	0.15	0.15	0.00	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	9.70	2.37	0.00	0.00	0.22	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	0.91	0.00	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.28	1.87	0.00	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	6.22	1.84	0.69	0.23	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	15.48	2.16	0.54	0.72	0.36	0.00	0.72	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.47	1.60	0.00	0.64	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	40.01	14.09	0.00	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	43.99	16.33	1.30	0.37	0.56	0.00	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	50.27	13.17	0.66	0.44	0.00	0.22	0.66	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	12.17	1.98	0.28	0.28	0.28	0.57	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	22.74	4.17	0.00	0.00	0.00	0.38	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.07	3.29	0.00	0.00	0.66	0.00	0.00	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	56.66	37.44	1.88	1.30	1.45	0.58	1.45	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	44.96	25.95	2.11	0.30	0.91	0.00	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	54.49	37.67	1.90	0.24	0.47	0.00	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	43.36	24.27	0.33	0.67	0.84	0.67	0.84	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.88	23.74	0.83	1.10	0.28	0.55	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	40.66	21.57	1.49	0.50	0.25	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	33.29	21.15	0.98	0.20	1.17	0.20	0.78	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.54	20.48	0.89	0.00	0.71	0.18	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	30.47	18.06	0.65	0.22	0.22	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	40.74	20.60	0.23	0.23	1.17	0.70	0.23	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	24.82	1.58	0.00	0.53	0.00	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	25.52	0.00	0.00	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.94	29.01	1.64	1.78	2.08	0.74	0.89	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	29.53	23.15	1.40	0.40	1.60	0.00	0.00	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.07	17.07	0.62	0.00	0.62	0.21	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.33	23.79	2.06	0.69	1.37	0.00	0.23	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	31.22	18.32	0.23	0.00	0.45	0.00	0.00	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.75	15.71	0.87	0.44	0.44	0.00	0.00	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	43.04	27.17	0.81	0.54	1.08	0.81	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	42.57	27.22	1.05	0.87	1.40	0.35	1.57	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	44.19	27.77	1.26	0.00	2.52	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	41.52	20.02	0.92	0.18	0.73	0.37	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	45.09	21.84	0.35	0.00	0.70	0.00	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	45.19	21.06	0.44	0.00	0.88	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	50.05	24.24	1.39	0.35	1.22	0.87	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.08	17.47	1.49	0.37	1.86	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.92	20.69	0.86	0.00	1.08	0.43	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	47.91	17.61	1.64	0.82	1.23	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.35	19.01	0.46	0.00	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.48	16.70	0.23	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	11.77	5.01	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	10.63	5.31	0.00	0.23	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	7.80	3.47	0.00	0.43	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	13.86	15.11	0.16	0.00	0.31	0.00	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	11.53	8.03	0.00	0.17	0.35	0.17	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	27.43	22.52	0.22	0.22	0.22	0.00	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	12.25	5.87	0.00	0.26	0.00	0.00	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	9.66	4.17	0.00	0.00	0.22	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	11.16	3.79	0.00	0.42	0.21	0.21	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	7.46	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	3.11	0.00	1.04	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.12	1.60	0.00	0.53	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	4.82	0.00	0.54	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.85	2.81	0.00	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.90	1.57	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	9.23	3.95	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	69.86	8.22	0.82	0.82	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	72.54	11.61	1.45	0.00	0.00	1.45	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	77.24	16.66	0.50	0.50	0.50	0.00	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.02	1.62	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.60	0.00	0.00	0.00	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	18.07	5.02	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	20.79	5.06	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	8.27	1.50	0.00	0.00	0.00	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.95	1.35	0.00	0.45	0.00	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	49.99	12.14	0.00	1.07	0.71	0.36	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	46.54	8.57	0.61	0.00	2.45	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	34.16	7.32	0.30	0.30	0.30	0.61	0.00	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7.91	4.34	0.26	0.00	0.26	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	8.98	1.57	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.75	1.15	0.00	0.29	0.29	0.00	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.59	5.22	0.00	0.00	0.00	0.00	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.94	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.68	4.19	0.43	0.00	0.00	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.02	4.24	0.68	0.34	0.34	0.17	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	11.45	3.39	0.16	0.00	0.16	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	1.34	0.00	0.90	0.00	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.54	2.45	0.00	0.35	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	4.40	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	14.76	4.64	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.28	3.95	0.62	0.21	1.04	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.71	4.34	0.00	0.00	1.00	0.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	43.24	13.87	0.54	0.54	0.54	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	56.27	17.15	0.00	0.54	0.54	0.54	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	14.35	0.00	1.79	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.54	2.60	0.19	0.19	0.00	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.91	2.82	0.43	0.43	0.43	0.22	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.38	3.99	0.00	0.21	0.21	0.00	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.74	5.06	0.51	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	15.16	1.73	0.00	0.43	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	16.13	3.05	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.27	3.96	0.00	0.49	0.00	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	0.92	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	1.40	0.00	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	19.66	5.26	0.28	0.00	0.00	0.00	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	17.91	4.17	0.00	0.25	0.25	0.25	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	3.08	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	15.40	4.66	0.36	0.00	0.00	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	1.38	0.00	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	20.30	8.51	0.65	0.00	0.00	0.98	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	21.78	5.63	0.00	0.75	0.75	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	36.61	6.31	0.50	0.25	0.00	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	64.46	6.19	0.69	0.00	0.46	0.69	3.21	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	61.83	4.79	1.44	0.72	0.48	0.24	4.31	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	53.08	7.93	1.09	0.55	1.37	0.27	3.83	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	46.23	7.21	1.20	0.90	0.90	1.20	2.40	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	69.59	6.72	0.00	0.00	0.24	1.20	4.32	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	65.71	7.96	0.91	0.23	0.45	0.45	1.59	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	55.84	6.74	1.74	0.00	0.00	0.43	2.82	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	60.54	8.16	0.79	0.53	1.84	1.05	2.37	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	64.26	6.33	1.88	0.23	1.64	2.35	1.88	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	64.30	7.25	1.81	1.21	0.60	1.51	3.92	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	57.52	8.72	1.45	0.29	0.58	0.29	2.61	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	58.62	9.06	0.53	0.80	0.53	0.27	1.33	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	116.44	8.32	0.44	0.88	0.44	0.00	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	117.50	12.75	1.37	0.00	1.37	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	142.46	21.63	1.49	0.00	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	61.95	7.20	1.80	0.72	0.72	1.80	1.80	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	63.87	8.34	1.73	1.15	0.86	0.86	2.01	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	78.49	8.25	1.65	0.47	0.47	0.47	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	65.92	4.12	0.63	0.00	0.63	0.63	3.17	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	63.67	8.30	0.00	0.31	0.31	0.31	2.77	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	67.00	3.21	2.24	0.32	1.28	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	59.66	6.50	1.15	1.15	1.53	0.76	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	56.75	5.91	1.58	0.00	0.00	0.79	1.97	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.17	12.10	0.00	0.00	2.27	1.51	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	117.23	12.85	0.00	0.80	1.61	1.61	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	114.01	11.89	1.40	0.70	0.00	1.40	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	109.19	11.02	6.01	0.00	0.00	2.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	93.21	7.31	0.00	1.83	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	24.70	1.98	0.00	1.48	0.99	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	17.36	1.89	0.11	0.42	0.11	0.11	0.53	0.21
Chondrocyte - de diff, donor1	11261-116G1	7.97	2.08	1.04	0.00	0.00	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	5.33	1.78	0.00	0.36	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	4.78	1.14	0.11	0.34	0.23	0.11	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	27.75	4.48	0.00	0.90	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.94	4.45	0.00	0.00	0.40	0.00	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	132.20	12.16	2.30	4.13	1.15	2.30	1.38	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	60.71	7.48	0.86	1.92	0.86	0.64	1.07	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	72.92	6.55	1.24	1.15	0.44	0.80	0.71	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	79.87	14.31	1.47	0.28	1.38	0.92	1.47	0.64
Corneal Epithelial Cells, donor1	11526-119I5	7.47	1.54	0.00	0.00	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.90	2.30	0.26	0.26	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.87	9.25	0.33	1.98	0.17	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.75	7.89	0.00	0.95	0.63	1.58	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.06	4.21	0.43	0.76	0.65	0.32	0.43	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.12	1.37	0.00	0.34	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.31	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.42	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.84	1.83	0.00	0.50	0.00	0.00	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	1.76	0.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	1.70	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	3.93	0.39	0.00	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.96	2.04	0.29	0.00	0.00	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	19.06	2.12	0.47	0.24	0.24	0.47	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	17.71	3.68	0.53	0.00	0.18	0.18	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.06	3.55	0.22	0.22	0.00	0.00	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.91	3.04	0.30	0.00	0.30	0.00	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.73	3.38	0.00	0.00	0.56	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	5.65	0.89	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	3.12	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.53	0.85	0.00	0.00	0.28	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	14.40	1.60	0.00	0.00	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	1.05	1.05	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.35	3.85	0.25	0.75	0.25	0.12	0.12	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.55	3.04	0.43	0.22	0.00	0.22	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	35.91	4.64	0.61	0.00	0.37	0.00	0.00	0.49
Endothelial Cells - Vein, donor1	11267-116G7	11.38	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	1.40	0.00	0.00	0.00	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	20.41	2.04	0.47	0.16	0.16	0.00	0.16	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	47.86	44.56	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	32.10	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.28	1.47	0.49	0.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.85	2.05	0.00	0.82	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.24	1.97	0.33	0.11	0.44	0.22	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.18	1.08	0.22	0.11	0.65	0.33	1.30	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.97	2.55	0.12	0.36	0.12	0.24	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.42	8.46	0.27	0.00	0.55	0.00	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.81	3.06	1.05	0.11	0.42	0.53	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.65	2.63	0.79	0.26	0.79	0.26	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.92	5.32	1.33	1.00	0.66	0.00	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	19.51	2.27	0.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.78	1.10	0.16	0.00	0.16	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	107.00	11.52	0.00	1.82	0.30	0.00	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	34.77	4.57	1.02	0.51	0.76	0.38	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	39.41	4.09	1.06	0.76	0.45	0.91	0.30	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	88.43	6.03	0.67	1.61	0.13	0.67	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	56.09	5.61	2.16	1.29	0.00	0.86	0.86	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	1.46	2.93	1.46	0.00	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	31.83	2.77	0.00	0.46	0.00	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	45.45	5.60	0.51	0.68	0.68	0.34	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	29.35	3.05	0.47	0.70	0.47	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	14.62	1.89	0.00	0.00	0.47	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	20.31	3.87	0.36	0.12	0.24	0.24	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	26.45	2.83	0.68	0.90	0.23	0.23	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	44.49	4.36	1.74	0.35	0.00	0.35	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	37.68	3.74	0.65	0.65	0.32	0.49	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	50.60	4.79	0.42	0.42	0.62	0.42	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.01	6.29	1.31	0.00	0.79	0.26	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	41.12	3.95	1.19	1.05	0.40	1.05	1.05	0.40
Fibroblast - Gingival, donor3	11394-118C8	61.49	5.32	0.97	0.77	0.77	0.58	0.29	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	2.08	1.04	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.04	2.64	0.70	0.18	0.35	0.18	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.49	4.05	0.31	0.00	0.00	0.31	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.12	4.46	0.95	0.41	0.54	0.00	0.27	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	60.70	9.17	0.00	0.00	0.00	0.00	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.62	4.97	0.73	0.58	0.44	0.15	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.32	4.36	0.68	0.27	0.82	0.14	0.27	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.52	4.94	0.99	0.22	0.11	0.11	0.55	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.73	6.46	0.29	0.29	0.44	0.15	0.00	0.59
Fibroblast - Lung, donor1	11270-116H1	13.59	2.72	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	35.81	5.97	0.00	1.49	0.00	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	28.91	2.74	1.06	0.84	1.06	0.21	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	40.82	9.16	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	1.40	0.00	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.96	1.68	0.28	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	48.31	5.68	0.00	0.00	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	26.38	3.30	0.00	0.19	0.39	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	54.30	3.34	2.43	1.06	1.52	0.00	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	62.73	9.18	0.61	0.00	0.61	0.92	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.94	5.72	1.91	0.00	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.99	2.97	0.00	0.54	0.27	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.98	5.33	0.35	0.12	0.23	0.23	0.00	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.37	2.21	0.00	0.11	0.00	0.22	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.99	2.44	0.00	0.00	0.00	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.71	2.00	0.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.05	2.77	0.00	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.67	2.18	0.40	0.00	0.00	0.00	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.33	1.07	0.18	0.00	0.18	0.18	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5.12	0.99	0.00	0.00	0.20	0.00	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.92	1.81	0.00	0.00	0.30	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	7.23	0.97	0.11	0.11	0.22	0.00	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	6.07	2.78	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	4.10	0.66	0.00	0.00	0.16	0.00	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.24	5.41	0.00	0.40	0.40	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	5.22	1.41	0.20	0.20	0.10	0.00	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	14.81	4.53	0.30	0.00	0.30	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	7.70	2.15	0.08	0.00	0.17	0.17	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	11.45	2.39	0.51	0.00	0.00	0.00	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.88	2.63	0.00	0.00	0.00	0.00	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.05	3.52	0.11	0.11	0.11	0.21	0.21	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	7.76	1.35	0.00	0.00	0.00	0.17	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1.57	0.31	0.31	0.16	0.00	0.00	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	8.72	5.23	0.00	0.00	1.74	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.84	1.56	0.17	0.52	0.00	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.29	4.16	0.00	0.00	0.00	0.52	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.52	2.30	0.00	0.26	0.00	0.26	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	1.53	0.00	0.00	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.93	0.64	0.00	1.28	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.85	0.57	0.57	0.86	0.00	0.57	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	32.26	1.93	1.10	1.65	0.28	1.93	0.00	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	43.84	5.94	1.83	0.91	0.46	0.46	0.23	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	12.09	0.79	0.40	0.40	0.40	0.40	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	36.74	2.38	0.53	1.32	0.26	1.32	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.68	3.59	0.00	2.28	0.33	0.65	0.00	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	0.44	0.00	0.00	0.00	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.33	1.27	0.28	0.57	0.00	0.00	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.76	1.23	0.37	0.00	0.37	0.12	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.21	0.54	0.54	0.00	0.00	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.72	0.25	0.62	0.25	0.74	0.50	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.29	0.97	1.52	0.28	0.42	0.42	0.69	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.03	0.41	0.20	0.20	0.20	0.41	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.20	0.91	0.00	0.46	0.46	0.00	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.21	0.87	0.62	0.50	0.12	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	1.53	0.00	0.00	0.00	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.96	0.89	0.30	0.59	0.59	0.30	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.82	2.23	1.11	0.32	0.79	0.16	1.27	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.53	1.34	0.67	0.45	0.45	0.00	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.35	1.61	0.00	1.01	0.60	0.40	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.19	0.68	0.34	0.00	0.34	0.51	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.64	1.86	0.53	0.27	0.44	0.27	0.27	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.60	1.87	0.21	0.83	0.31	0.31	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.71	1.71	0.17	0.00	0.51	0.00	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.91	1.33	0.44	0.22	0.11	0.11	0.77	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.30	1.66	0.08	0.42	0.17	0.08	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.15	1.02	0.20	0.41	0.00	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.58	1.86	0.83	0.00	0.21	0.62	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.22	1.27	0.58	0.23	0.46	0.46	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.51	1.00	0.50	0.00	0.50	0.50	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.53	0.44	0.44	0.00	0.44	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.13	1.48	0.86	0.12	0.00	0.12	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.07	3.73	0.16	0.32	0.49	0.16	0.65	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.85	1.60	0.32	0.32	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.90	0.66	0.19	0.47	0.38	0.28	0.85	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	16.29	2.21	0.00	0.32	0.00	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.08	1.82	0.00	0.61	0.00	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.66	1.05	0.42	0.21	0.21	0.10	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.93	0.88	0.22	0.22	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.99	1.68	0.00	0.00	0.28	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	12.50	0.83	0.37	0.00	0.46	0.00	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.90	1.07	0.27	0.00	0.53	0.00	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.22	2.75	0.15	0.15	0.31	0.15	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.12	1.30	0.26	0.00	0.00	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.62	2.71	0.54	0.00	0.27	0.54	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.38	1.66	0.18	0.00	0.00	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.60	1.54	0.88	1.10	0.44	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	50.58	6.94	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.15	1.58	0.26	0.13	0.40	0.00	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.34	2.42	0.00	0.40	0.20	0.20	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	65.83	13.47	0.25	0.00	0.76	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.76	1.19	0.20	0.00	0.60	0.00	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.63	0.62	0.31	0.15	0.00	0.00	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.96	0.82	0.20	0.00	0.20	0.20	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.20	0.00	0.31	0.00	0.00	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3.11	0.57	0.00	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.22	1.84	0.00	1.38	0.00	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	4.95	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.44	1.16	0.00	1.16	0.00	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	0.00	0.00	3.21	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	1.74	1.74	0.00	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	12.37	2.28	0.65	1.63	0.33	0.98	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.82	0.00	0.00	0.82	0.82	0.82	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	3.33	3.33	0.00	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.30	2.24	0.56	0.56	0.56	0.56	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	0.98	0.33	0.65	0.65	1.31	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	23.49	1.68	0.00	0.84	0.00	1.68	5.87	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.67	1.27	0.64	0.95	0.32	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.89	1.36	0.34	0.00	0.00	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	24.05	0.00	0.57	1.72	1.15	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.84	0.59	0.30	0.59	0.00	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	0.00	0.00	0.00	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.43	1.66	0.83	1.24	0.00	0.83	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.64	0.92	0.23	0.92	0.00	0.46	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.61	2.31	1.54	1.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	1.63	0.65	0.33	0.00	0.65	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	0.00	0.00	0.00	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	20.03	0.77	0.00	0.39	0.39	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.78	3.08	0.34	0.68	0.34	0.00	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	0.00	2.48	0.00	0.00	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	0.94	0.47	1.42	0.00	0.94	0.47	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.92	1.21	1.81	0.60	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.98	0.51	1.02	0.51	1.53	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	20.74	1.99	0.80	1.60	1.60	0.80	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	20.23	0.49	0.99	1.48	0.49	0.99	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	2.36	0.00	1.18	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.92	1.17	0.00	1.17	0.00	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.51	1.76	0.44	1.76	0.88	0.00	0.44	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	1.70	0.85	1.70	1.70	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	2.39	1.19	1.79	1.19	1.19	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	1.94	0.00	0.00	0.97	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	3.42	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.98	1.66	0.42	0.00	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	2.25	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.84	5.39	0.32	0.63	0.32	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	3.34	0.42	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	1.62	0.12	0.00	0.00	0.00	0.12	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	1.86	0.17	0.00	0.17	0.00	0.00	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	1.37	0.46	0.00	0.00	0.00	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.87	0.55	0.11	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	1.07	0.00	0.21	0.00	0.00	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2.15	0.22	0.22	0.00	0.22	0.22	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.25	0.12	0.12	0.00	0.12	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.69	0.17	0.17	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.96	0.32	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.27	2.24	0.56	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.77	3.03	0.43	0.43	0.00	0.43	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	24.69	2.47	0.00	0.00	0.00	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.89	2.91	1.45	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.99	0.87	0.70	0.52	0.00	0.00	0.87	0.00
Hepatocyte, donor1	11523-119I2	115.01	26.63	2.42	2.42	2.42	1.21	4.84	0.00
Hepatocyte, donor2	11603-120I1	90.50	15.08	3.23	2.15	2.15	2.15	2.15	3.23
Hepatocyte, donor3	11684-122I1	106.76	20.25	0.61	1.23	4.91	0.61	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	8.48	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	32.86	4.54	0.70	1.05	0.70	0.17	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.15	2.61	0.41	0.41	0.27	0.55	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	1.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	1.62	0.00	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	5.29	0.00	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	0.00	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	1.26	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	1.55	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.98	1.29	0.00	0.00	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	1.61	0.00	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	3.26	0.81	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	1.68	0.00	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	0.00	0.00	0.80	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	0.92	0.00	0.00	0.92	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.08	0.94	0.47	0.00	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	2.72	0.00	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	3.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	2.55	0.00	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	0.71	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.49	2.47	0.62	0.00	0.62	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	1.76	0.00	0.00	0.00	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	1.39	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	2.21	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	0.00	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	2.13	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	5.54	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	0.00	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.47	3.10	0.16	0.24	0.16	0.16	0.00	0.24
Keratinocyte - epidermal, donor2	11349-117G8	4.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.47	2.18	0.19	0.09	0.00	0.00	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	14.87	1.70	0.11	0.68	0.11	0.11	0.34	0.11
Keratocytes, donor1	11527-119I6	26.48	3.09	0.00	0.34	0.00	0.00	0.69	0.34
Keratocytes, donor2	11607-120I5	71.48	8.20	1.17	2.34	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	44.06	3.16	0.59	0.59	0.40	0.59	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	6.59	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	0.00	0.00	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	68.28	4.38	0.23	0.81	0.12	1.15	1.04	0.23
Lens Epithelial Cells, donor3	11690-122I7	24.72	6.16	0.00	0.00	0.20	0.10	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.47	0.71	0.24	0.12	0.12	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	0.84	0.00	0.00	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.82	2.05	0.31	0.31	0.16	1.10	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	0.54	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	0.63	0.00	0.95	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.42	1.29	0.00	0.22	0.11	0.43	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.16	0.82	0.00	0.41	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	0.51	0.00	0.00	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.30	0.99	0.14	0.14	0.00	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.14	1.19	0.00	0.40	0.40	0.40	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.65	0.39	0.19	0.19	0.00	0.00	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	0.37	0.37	0.19	0.37	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	0.70	0.00	0.00	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.92	0.95	0.24	0.24	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.63	0.82	0.41	0.14	0.14	0.14	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.31	0.31	0.00	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.05	0.31	0.00	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	0.37	0.37	0.00	0.00	0.37	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.28	0.33	0.00	0.33	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	0.59	0.00	0.00	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.73	0.25	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.62	1.62	0.00	0.00	0.00	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.81	1.06	0.45	0.30	0.00	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	0.42	0.00	0.42	0.00	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.56	1.80	0.15	0.30	0.15	0.30	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	0.69	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.02	0.75	0.19	0.00	0.19	0.00	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.00	0.85	0.11	0.21	0.00	0.21	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.85	1.45	0.00	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	0.99	0.00	0.00	0.00	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.43	1.12	0.50	0.37	0.00	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.00	1.48	0.37	0.37	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	0.49	0.00	0.00	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.99	0.82	0.41	0.00	0.14	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.11	1.29	0.64	0.32	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.56	0.91	0.00	0.00	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.64	0.70	0.56	0.28	0.14	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.47	1.42	0.00	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	1.09	0.00	0.00	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	0.36	0.00	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	1.96	0.00	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	0.71	0.24	0.00	0.00	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.93	1.24	0.25	0.12	0.00	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.35	1.54	0.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	0.90	0.30	0.60	0.00	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5.37	0.00	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	0.74	0.00	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	2.96	0.42	0.00	1.27	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	5.63	1.41	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	0.93	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	2.58	1.03	1.03	0.00	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	0.00	0.00	0.00	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.01	1.36	0.00	0.00	0.00	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.82	0.58	0.58	0.58	0.29	0.00	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.65	1.35	0.45	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.75	1.90	0.54	0.14	0.14	0.00	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	3.08	0.00	0.51	1.03	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.12	1.76	0.35	0.00	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.68	2.55	1.02	0.51	0.00	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.01	2.13	0.53	0.00	0.27	0.27	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.53	3.02	0.38	0.19	0.57	0.19	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	1.84	0.61	0.00	0.00	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	3.26	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.20	2.92	0.62	0.00	0.83	0.00	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.73	3.36	0.56	0.56	0.56	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	5.15	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.58	3.77	0.00	0.58	1.16	0.00	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	0.90	0.60	0.60	0.00	0.60	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	3.87	0.00	0.00	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.32	5.30	0.71	0.35	1.06	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.28	1.48	0.74	0.00	1.11	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	3.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.75	2.30	1.15	0.00	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.36	2.26	0.00	0.00	1.13	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.82	1.81	0.90	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.77	2.87	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	0.75	0.00	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.84	4.46	1.49	0.00	2.23	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.77	0.86	0.86	0.00	0.86	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	3.43	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.00	2.00	0.33	0.33	0.00	0.00	2.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.64	1.21	0.00	1.81	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	0.00	0.00	0.00	0.71	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.00	2.41	0.34	0.00	0.00	0.34	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	3.76	0.00	0.54	0.00	0.00	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	7.41	2.02	0.00	0.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	2.96	0.00	0.00	0.74	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1.16	2.33	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	3.20	0.80	0.00	1.20	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	1.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	8.43	1.53	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.91	3.45	0.00	0.00	0.49	0.00	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	2.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	2.01	0.00	0.00	0.00	0.00	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.46	3.15	0.00	0.00	0.90	0.00	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	1.72	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.13	1.78	0.00	0.45	1.34	0.00	2.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.99	2.74	0.39	0.00	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.90	3.96	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.90	2.59	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.06	1.75	0.00	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	1.12	0.00	0.00	0.00	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.27	3.53	0.88	0.00	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.57	1.93	0.39	0.00	0.39	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	2.53	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	3.36	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.72	2.78	0.40	0.40	0.80	0.00	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	3.65	0.61	0.00	0.00	0.00	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	2.08	0.00	0.00	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	4.18	1.90	0.00	0.00	0.76	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.39	2.07	0.52	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	2.42	1.21	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.48	3.17	0.95	0.63	1.27	0.00	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	5.33	0.00	0.00	0.53	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	0.57	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	4.11	1.03	0.00	2.57	0.00	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.03	3.54	2.12	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	2.84	1.13	0.00	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.90	4.16	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	3.92	1.57	0.00	1.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	1.25	0.42	0.42	0.84	0.42	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.55	2.79	2.32	0.46	0.46	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	0.67	0.00	0.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.25	3.74	1.60	0.00	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	5.66	0.81	0.00	0.00	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	1.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	2.67	0.00	0.00	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.66	6.27	0.00	0.00	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	5.37	0.00	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.59	2.74	1.09	0.00	0.00	0.55	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.04	1.34	0.89	0.00	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.96	2.60	0.26	0.00	0.78	0.00	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	2.65	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	4.16	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	8.89	3.65	0.00	0.46	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	12.29	3.49	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	17.17	4.06	0.92	0.66	0.26	0.26	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	1.06	0.00	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.87	3.17	0.00	0.48	0.00	0.00	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	4.45	1.67	0.00	0.00	0.00	0.00	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	19.53	6.08	0.20	0.60	0.20	0.70	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	14.48	3.47	0.00	0.00	0.58	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.73	2.00	0.00	0.00	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	122.03	79.32	10.17	0.00	14.24	8.14	2.03	5.42
Mast cell, donor1	11563-120D6	95.38	22.93	0.76	0.54	1.08	1.08	0.22	1.84
Mast cell, donor2	11565-120D8	88.56	11.29	1.19	0.00	1.19	0.00	0.00	1.19
Mast cell, donor3	11566-120D9	97.25	14.63	2.03	0.00	0.90	0.23	0.00	0.90
Mast cell, donor4	11567-120E1	81.73	15.25	1.60	0.35	0.71	0.35	0.00	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	59.66	23.62	1.66	0.78	0.89	0.44	1.11	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	73.54	15.18	2.92	1.17	1.75	2.33	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	53.00	13.77	1.38	0.92	1.03	0.92	0.46	1.49
Mast cell, expanded, donor8	11941-126A6	84.19	22.43	1.67	0.67	1.51	0.33	0.00	2.18
Melanocyte - dark, donor1	11502-119F8	10.45	0.80	0.00	0.00	0.00	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	24.23	3.81	1.38	0.00	0.35	0.35	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	12.17	1.52	0.14	0.36	0.14	0.07	0.07	0.00
Melanocyte - light, donor1	11274-116H5	4.70	0.94	0.24	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	4.78	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.00	0.00	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	3.85	0.31	0.00	0.10	0.10	0.00	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	4.03	0.00	0.00	0.00	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	21.43	0.27	0.27	0.27	0.00	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	49.50	2.85	0.87	0.12	0.25	0.25	0.12	0.50
Meningeal Cells, donor2	11573-120E7	27.73	3.08	0.88	0.00	0.00	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	31.54	2.20	0.16	0.41	0.33	0.49	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	25.66	2.28	0.29	1.14	0.57	0.86	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.06	3.62	0.00	0.40	0.10	0.20	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	2.62	0.00	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	11.48	2.15	0.72	0.00	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	2.75	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	2.51	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.25	3.96	0.22	0.00	0.22	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	49.68	2.19	0.00	0.73	0.73	0.00	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	32.74	3.89	1.02	0.41	0.41	0.00	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.00	1.94	0.00	0.14	0.14	0.00	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.82	3.35	0.00	0.00	0.00	0.74	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.71	2.76	0.39	0.79	0.39	0.79	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.09	3.26	0.89	0.00	0.59	0.30	1.19	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	2.34	2.34	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	16.01	1.28	0.00	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.60	2.13	0.00	0.71	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.52	1.88	0.00	0.94	0.00	1.25	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.90	0.00	0.00	1.45	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	18.83	7.16	0.27	1.33	0.27	1.06	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	20.52	5.00	0.00	0.00	0.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	17.63	3.69	0.43	0.72	0.51	0.29	0.22	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	5.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.59	2.96	0.99	0.25	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.43	3.53	0.29	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.82	2.79	0.00	0.00	0.00	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.39	2.07	0.41	0.21	0.21	0.21	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.01	3.75	0.00	0.50	0.00	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.50	2.03	0.20	0.20	0.20	0.81	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	1.58	0.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	0.00	1.77	0.00	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.66	3.04	0.38	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.46	1.49	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	1.79	0.00	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.27	1.00	0.00	0.25	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.42	0.95	0.00	0.95	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	3.32	0.00	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.14	2.07	0.00	0.46	0.00	0.00	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.47	1.89	0.00	0.21	0.42	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.21	3.06	0.00	0.00	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.65	1.29	0.00	0.43	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.78	2.22	0.00	0.22	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	1.97	0.00	0.00	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	2.03	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.88	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	2.94	0.00	0.00	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	5.45	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	0.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.00	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	2.74	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.00	0.50	0.50	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	1.31	0.00	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	3.31	0.00	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.93	1.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.20	0.99	0.00	0.25	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	3.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	1.71	0.00	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	3.06	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.93	1.68	0.28	0.84	0.84	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	4.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	4.08	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	2.71	0.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	2.50	0.00	0.42	0.42	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.40	1.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.50	2.76	0.00	0.14	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.44	1.81	0.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.15	1.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	3.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.14	3.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.67	4.49	0.00	0.30	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.88	1.84	0.00	0.28	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.46	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.52	2.87	0.00	0.22	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	13.65	1.90	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	2.27	0.00	0.28	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.64	3.20	0.00	0.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	7.82	0.00	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.35	5.00	0.88	0.29	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.55	3.46	0.00	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.97	6.59	0.41	0.00	0.82	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.87	4.47	0.30	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.23	0.99	0.00	0.00	0.33	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.76	1.78	0.00	0.40	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4.66	0.00	0.00	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.26	1.50	0.00	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.06	1.60	0.27	0.00	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.64	1.02	0.11	0.23	0.11	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	0.00	0.00	0.00	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	1.47	0.00	0.00	0.00	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	6.22	1.56	0.00	0.00	3.11	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	1.07	0.00	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.75	2.11	0.42	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	14.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.93	3.45	0.22	0.00	0.22	0.00	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	2.09	0.00	0.00	0.00	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	46.06	5.34	0.67	0.67	0.67	0.67	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	98.08	3.76	0.83	0.42	0.83	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	27.95	5.13	0.38	0.38	0.38	0.38	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	114.90	6.38	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	38.08	7.48	0.00	0.00	1.36	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	5.51	1.84	1.84	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	2.09	0.84	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	35.33	2.56	0.23	0.70	0.46	0.23	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.91	3.24	0.27	0.00	0.00	0.00	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.06	4.41	0.42	0.21	0.42	0.00	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	31.77	5.96	0.50	0.00	0.50	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.56	1.89	0.00	0.27	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.89	2.49	0.68	0.23	0.68	0.00	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.82	2.45	0.16	0.49	0.00	0.16	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.60	6.01	0.91	0.00	0.36	0.18	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	32.36	5.83	0.00	0.00	0.00	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.61	4.20	0.60	0.00	0.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.46	2.95	0.00	0.66	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	25.21	2.28	0.65	0.00	0.49	0.00	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.51	6.88	0.88	0.00	0.00	0.00	0.18	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	34.46	4.22	1.41	0.00	0.00	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	2.30	0.00	0.46	0.00	0.00	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	2.57	0.64	0.00	0.32	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.45	2.76	0.69	0.69	0.34	0.69	1.72	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	10.11	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.09	3.56	0.22	0.45	0.22	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.75	2.12	0.42	0.00	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	2.61	0.47	0.71	0.24	0.24	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.02	0.86	0.00	0.00	0.86	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	9.03	0.00	0.00	0.00	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.66	2.00	0.67	0.00	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.52	4.51	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.24	1.98	0.40	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	3.71	1.86	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	0.00	1.14	0.00	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.35	6.84	0.00	0.98	0.65	0.00	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.68	2.18	0.44	0.44	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.54	4.52	0.00	0.00	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	1.76	0.00	0.00	1.76	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.93	1.33	1.33	0.66	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	2.48	0.00	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	3.83	0.38	0.00	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	1.21	0.00	0.00	0.60	0.30	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.54	3.09	0.22	0.22	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	6.10	0.00	1.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.14	4.09	0.00	0.00	0.63	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.58	1.51	0.00	0.30	0.30	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	1.58	0.79	0.79	0.79	0.00	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	7.94	3.40	0.00	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	28.95	5.34	0.12	1.24	0.50	0.62	1.12	0.00
Myoblast, donor2	11322-117D8	84.58	8.44	4.79	2.30	2.69	0.96	1.92	1.34
Myoblast, donor3	11398-118D3	57.34	9.08	0.50	1.01	0.17	0.67	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.87	27.58	0.73	0.29	0.44	0.58	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	47.36	15.68	0.92	0.92	0.62	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	42.22	13.57	1.21	1.21	1.51	1.81	0.60	0.90
Natural Killer Cells, donor3	11387-118C1	79.88	17.49	0.92	0.74	0.92	0.92	1.66	0.37
Neural stem cells, donor1	11275-116H6	94.00	11.98	1.81	0.73	0.73	0.36	1.09	0.73
Neural stem cells, donor2	11352-117H2	80.88	21.18	0.00	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	30.72	6.83	1.14	2.28	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	15.41	6.60	0.22	0.66	0.44	0.00	0.00	0.00
Neurons, donor3	11655-122E8	19.73	1.64	0.82	0.82	0.82	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	31.55	20.42	0.00	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	52.18	31.89	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	48.26	27.49	0.00	0.00	0.61	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	85.25	7.24	1.07	1.19	0.24	0.83	1.19	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	31.26	1.95	0.33	2.28	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	27.68	1.60	1.60	2.61	0.60	1.40	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	9.36	2.62	0.14	0.41	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	6.37	2.32	0.58	0.14	0.72	0.14	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	6.02	1.82	0.00	0.11	0.23	0.11	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	17.04	3.21	0.10	0.39	0.29	0.10	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	1.81	0.00	0.00	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.21	2.13	0.64	0.00	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	5.59	1.86	0.00	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	6.64	0.98	0.20	0.20	0.00	0.20	0.20	0.39
Osteoblast, donor2	11354-117H4	12.64	2.11	0.00	0.70	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	25.95	4.62	0.89	0.00	0.71	0.00	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	6.23	1.01	0.08	0.34	0.00	0.25	0.17	0.17
Pericytes, donor1	11491-119E6	31.82	3.23	0.89	0.56	0.11	0.00	0.45	0.22
Pericytes, donor2	11571-120E5	28.52	2.26	0.45	0.00	0.23	0.45	1.13	0.00
Pericytes, donor3	11652-122E5	20.55	2.44	0.00	0.00	0.20	0.41	0.41	0.00
Perineurial Cells, donor1	11499-119F5	22.15	2.03	0.34	0.45	0.11	0.45	0.34	0.11
Perineurial Cells, donor2	11579-120F4	30.92	4.60	0.28	0.37	0.00	0.28	0.28	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	52.59	21.67	0.32	0.64	0.32	0.32	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	39.18	14.20	0.98	0.24	1.71	0.24	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	39.60	11.26	0.39	0.13	0.52	0.00	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	6.94	1.91	0.00	0.00	0.00	0.24	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	9.98	0.00	0.00	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	16.30	3.73	0.00	0.00	0.00	0.20	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.80	0.95	0.95	0.32	0.63	0.00	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	7.50	2.63	0.00	0.56	0.00	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.79	3.52	0.00	0.13	0.00	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	5.18	2.03	0.45	0.23	0.23	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	7.89	2.24	0.11	0.11	0.11	0.43	0.32	0.21
Preadipocyte - omental, donor2	11329-117E6	6.11	1.31	0.44	0.00	0.00	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	12.32	5.16	0.43	0.43	0.43	0.00	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	5.91	1.97	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.99	0.92	0.00	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	7.26	1.24	0.18	0.18	0.35	0.18	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	8.85	2.04	0.17	0.00	0.34	0.00	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	16.39	3.07	0.19	0.47	0.09	0.19	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	15.19	4.14	0.92	0.46	0.46	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	8.78	1.46	0.52	0.31	0.10	0.31	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.68	3.02	1.21	0.60	0.15	0.60	0.75	1.06
Prostate Epithelial Cells, donor2	11331-117E8	8.12	2.30	0.27	0.14	0.41	0.27	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	12.98	3.25	0.31	0.06	0.31	0.12	0.24	0.43
Prostate Stromal Cells, donor1	11254-116F3	16.97	3.42	0.11	0.68	0.46	0.00	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	25.46	4.30	1.08	0.72	0.72	0.36	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	25.86	3.55	1.04	0.52	0.94	0.31	0.94	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	54.38	3.28	1.09	0.36	0.00	0.73	1.09	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.81	2.70	0.21	1.11	0.62	0.55	0.35	0.28
Renal Epithelial Cells, donor1	11517-119H5	54.78	4.57	0.00	0.00	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	71.13	2.13	4.27	0.71	0.71	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	66.69	6.35	0.32	2.86	0.74	1.38	1.06	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	2.04	0.00	0.68	0.00	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	20.89	2.29	0.40	0.13	0.27	0.27	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.30	6.66	1.78	0.22	0.67	0.67	0.44	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.97	1.33	0.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	62.51	6.16	0.44	1.76	0.22	0.22	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	99.69	9.40	3.76	5.02	1.88	1.88	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	51.60	4.72	1.11	1.11	0.28	0.28	0.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	39.19	6.98	0.00	0.54	0.54	0.27	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.45	3.80	0.00	0.42	0.42	2.53	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	71.35	5.98	1.74	0.96	0.77	0.58	1.35	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.93	0.52	0.00	0.26	0.26	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.79	2.27	0.28	0.00	0.00	0.28	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	2.06	0.00	0.00	0.00	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.79	0.50	0.25	0.50	0.00	0.25	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	57.33	13.23	1.20	0.94	0.94	0.67	0.13	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	36.63	2.68	0.00	0.00	0.00	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	3.85	1.65	0.00	1.10	0.55	1.10	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.64	3.48	1.16	0.58	1.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	27.96	3.51	0.52	0.13	0.26	0.39	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.61	4.07	1.19	0.30	1.39	0.50	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.55	4.46	0.67	0.33	0.22	0.33	0.22	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.43	4.34	0.25	0.37	0.12	0.37	1.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.74	3.50	1.05	0.35	1.17	0.23	0.70	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	32.36	5.78	2.31	0.92	0.23	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.97	3.15	0.82	0.27	0.27	0.00	1.10	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.56	4.84	1.21	0.00	0.91	0.76	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.40	4.30	0.00	1.79	0.18	0.54	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	27.97	2.58	0.43	0.00	0.14	0.29	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.44	3.86	0.43	0.32	0.32	0.32	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.11	5.31	1.11	0.89	0.44	0.44	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	34.79	2.87	0.96	0.38	0.00	0.00	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.42	4.19	0.47	0.47	0.65	0.37	0.19	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	34.57	4.51	0.38	0.19	0.19	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	41.94	4.51	1.19	0.27	0.13	0.13	0.53	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	35.04	4.28	1.07	0.10	1.07	0.00	0.49	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.17	2.67	0.38	0.00	0.19	0.76	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.16	4.27	0.53	0.21	0.21	0.00	0.53	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.31	2.24	1.12	0.00	1.96	0.28	1.68	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	39.31	3.76	0.85	0.17	0.34	0.51	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.11	3.65	1.09	0.18	0.00	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	31.52	2.94	0.86	0.61	1.35	0.61	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.36	4.57	0.54	0.27	0.54	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.08	1.65	0.71	0.47	0.47	0.47	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.97	2.18	0.60	0.00	0.40	0.20	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.54	3.51	1.17	0.70	0.23	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.96	3.32	0.62	0.21	0.00	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.33	2.88	1.55	0.00	0.88	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.84	5.64	0.21	0.00	0.21	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.01	3.63	0.40	0.40	0.27	0.00	1.08	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	35.93	3.92	0.85	0.34	0.17	0.68	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.96	5.21	1.16	1.35	0.19	0.19	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.98	4.30	1.38	0.17	0.34	0.00	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.86	4.12	0.55	0.14	0.41	0.14	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	37.59	4.60	2.46	0.16	0.49	0.66	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	40.73	4.43	1.70	0.17	0.34	0.17	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.41	1.92	0.30	0.00	0.30	0.30	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.05	5.06	0.27	0.27	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.25	1.80	0.83	0.14	0.28	0.14	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.05	2.86	0.48	0.24	0.24	0.71	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	70.94	7.86	1.61	0.20	0.40	0.00	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.09	2.17	1.13	0.19	0.00	0.09	0.75	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.90	2.79	0.35	0.00	1.40	0.00	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.01	2.72	0.91	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	25.70	2.81	0.49	0.24	0.24	0.12	0.37	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	64.04	9.90	1.46	0.15	0.29	0.00	0.29	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	2.43	0.00	0.00	0.61	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.22	2.11	0.30	0.30	0.00	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.33	2.26	1.36	0.00	0.45	0.23	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.35	2.70	0.30	0.90	0.00	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.95	1.65	0.94	0.12	0.35	0.00	0.12	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.75	3.63	0.85	0.00	1.49	0.64	0.21	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	4.21	1.80	0.00	3.61	0.60	0.00	1.20
Schwann Cells, donor1	11498-119F4	25.58	1.88	0.56	1.13	0.00	0.19	0.19	0.19
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	24.54	1.97	0.00	0.44	0.00	0.44	1.97	0.22
Sebocyte, donor1	11220-116B5	24.65	6.03	0.00	0.00	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	8.27	1.38	0.00	0.00	0.00	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	20.82	2.68	0.41	0.21	0.41	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	4.97	3.31	1.66	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.20	1.85	0.09	0.18	0.09	0.18	0.35	0.26
Skeletal Muscle Cells, donor2	11358-117H8	2.89	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	36.29	3.77	0.94	0.79	0.47	0.94	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	37.01	3.72	1.34	0.45	0.89	0.74	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	40.17	3.39	1.54	0.31	0.15	0.31	0.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.47	4.41	0.38	0.38	0.63	0.50	0.38	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	54.36	6.42	1.00	0.86	1.71	0.86	0.71	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.99	4.76	0.99	0.79	0.20	0.40	0.69	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.80	2.02	0.08	0.25	0.08	0.25	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	1.45	0.00	0.00	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.23	2.20	0.28	0.28	0.00	0.00	0.14	0.14
Skin - palm, donor1	10286-104F7	29.55	5.37	2.69	0.00	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.64	1.59	0.14	0.14	0.14	0.00	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	32.72	12.27	3.27	0.00	3.27	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.29	1.82	0.52	0.13	0.52	0.00	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	2.36	0.42	0.14	0.14	0.00	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	18.43	3.52	0.56	0.28	0.28	0.28	0.56	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	53.92	16.07	0.42	0.21	0.63	0.42	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	27.66	4.57	0.90	0.30	0.15	0.15	0.30	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.71	1.54	0.00	0.31	0.00	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.34	4.67	0.22	0.00	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	1.18	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.63	2.21	0.00	0.00	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	2.36	0.39	0.39	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	2.32	0.00	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	83.06	6.00	2.00	0.00	2.00	0.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.25	1.06	0.13	0.00	0.00	0.13	0.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.42	2.22	0.22	0.00	0.22	0.22	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.53	1.41	0.13	0.00	0.13	0.13	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.88	2.60	0.00	0.98	0.33	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	26.58	4.13	0.00	0.89	0.30	0.89	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.21	3.27	0.57	0.14	0.43	0.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	21.47	2.77	0.00	0.16	0.00	0.16	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	38.66	2.13	1.22	0.91	0.61	0.61	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.88	2.78	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	0.00	0.00	0.00	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.09	1.62	0.29	0.59	0.00	0.74	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.86	2.37	1.29	0.22	0.43	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.74	3.25	0.42	0.21	0.42	0.31	0.21	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.76	2.17	0.00	0.00	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	3.23	0.00	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.86	2.39	0.60	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.48	4.44	0.00	0.00	0.34	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	57.25	4.48	0.47	1.73	0.31	0.63	1.26	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.86	6.84	0.91	0.30	0.50	0.10	0.30	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.61	3.41	0.46	0.46	0.23	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	0.60	0.60	0.60	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	32.59	3.44	0.26	0.53	0.26	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.59	1.46	0.00	0.00	0.00	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.54	4.26	0.75	0.63	0.63	0.38	0.50	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	3.30	1.27	0.00	0.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	18.70	3.62	0.30	0.30	0.15	0.00	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	5.25	0.00	0.00	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	2.58	0.00	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.91	1.40	0.47	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	1.01	0.00	0.50	0.50	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.15	1.25	0.94	0.00	0.31	0.00	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.29	2.65	0.59	0.29	0.59	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	44.90	4.17	0.00	0.92	0.00	0.58	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.56	2.80	0.93	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.07	3.17	0.14	0.00	0.00	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	1.53	0.51	0.00	0.25	0.00	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	1.32	0.00	0.19	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.02	1.68	0.00	0.56	0.28	0.56	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.90	1.93	0.08	0.34	0.00	0.25	0.50	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	1.90	0.48	0.00	0.00	0.00	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.74	2.45	0.24	0.00	0.00	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.50	3.31	0.22	0.00	0.00	0.22	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1.46	0.29	0.00	0.00	0.00	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	0.97	0.19	0.00	0.39	0.19	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.31	1.06	0.79	0.00	0.26	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.44	1.49	0.37	0.00	0.74	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.79	2.16	1.08	1.44	1.08	0.72	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	39.75	8.52	1.14	0.57	1.99	0.28	1.42	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.27	3.94	0.79	0.00	0.39	0.00	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.36	2.29	1.02	0.00	0.76	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	12.78	3.19	0.00	0.00	0.00	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	5.85	1.25	0.00	0.00	0.00	0.00	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	4.13	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	19.69	7.07	0.00	0.67	0.50	0.34	0.00	0.17
Synoviocyte, donor2	11368-117I9	5.53	2.18	0.17	0.17	0.17	0.00	0.34	0.17
Synoviocyte, donor3	11440-118H9	6.70	1.56	0.45	0.00	0.00	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	59.67	4.65	0.71	0.71	0.36	1.43	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	3.96	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	50.71	3.47	0.93	0.23	0.23	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.46	1.29	0.07	0.43	0.14	0.43	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	5.03	1.16	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	53.76	15.50	0.49	1.11	0.62	0.98	0.12	1.72
Urethra, donor2	10319-105A4	35.97	5.40	0.00	0.00	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	11.16	1.06	0.00	0.27	0.00	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	5.61	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.73	0.23	0.00	0.46	0.00	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	8.69	2.01	0.00	0.22	0.00	0.22	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	8.90	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	15.73	0.00	0.00	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.96	9.58	0.68	0.00	0.00	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.24	11.02	0.00	0.69	0.00	1.03	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	16.27	4.65	0.00	0.00	0.00	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	8.33	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	20.19	9.18	0.00	0.00	0.92	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	13.69	9.13	1.83	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.37	0.00	0.12	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	19.36	0.88	0.00	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.54	1.40	0.00	0.00	0.00	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	39.26	4.13	0.00	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	30.59	2.80	0.25	1.27	1.27	2.80	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	17.65	1.39	0.00	0.00	0.46	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	63.75	4.27	0.36	0.83	0.47	1.07	0.47	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.61	2.18	0.00	0.54	0.00	0.54	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	8.25	2.96	0.21	0.00	0.42	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.04	5.72	0.27	1.09	0.54	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.49	0.88	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	12.25	1.23	0.41	0.41	1.23	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	7.38	2.33	0.00	0.00	0.00	0.00	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.86	0.37	0.18	0.00	0.18	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.29	4.65	0.00	0.23	1.16	0.23	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.28	0.78	0.00	0.26	0.26	0.00	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	3.80	0.29	0.29	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.13	2.79	0.46	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.42	9.87	1.23	0.82	1.23	0.41	4.11	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	4.69	0.43	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.07	0.00	0.30	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.13	0.48	0.00	0.48	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.80	3.56	0.45	0.00	0.45	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.69	5.00	1.00	0.33	0.67	0.00	0.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	42.74	3.72	0.00	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	51.98	5.27	1.13	0.38	0.38	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	26.17	3.93	0.44	0.00	0.00	0.87	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	3.75	0.00	0.00	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.49	1.88	0.47	0.00	0.00	0.47	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	96.79	14.89	1.40	1.40	2.17	0.62	0.62	3.41
adipose, donor1	10184-103D4	17.59	4.10	0.59	1.76	1.76	2.93	1.17	6.45
adipose, donor2	10185-103D5	24.74	1.62	0.41	1.62	1.22	0.81	0.41	1.62
adipose, donor3	10186-103D6	30.77	6.26	0.82	1.09	1.09	0.82	0.00	2.45
adipose, donor4	10187-103D7	18.20	8.67	0.87	0.00	3.47	0.00	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.47	0.63	0.00	0.00	0.16	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	3.64	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	41.09	6.14	0.27	0.93	0.27	1.07	0.53	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.36	1.07	0.36	0.00	0.00	1.43	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	9.51	3.01	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	11.83	5.41	0.00	0.00	0.34	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	9.13	0.88	0.00	0.59	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	90.12	23.72	1.19	1.19	0.00	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	258.73	59.61	5.47	3.24	5.07	3.65	2.23	1.42
amygdala, newborn, donor10223	10360-105E9	30.02	10.97	0.65	0.00	0.65	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	17.44	2.16	0.13	0.25	0.13	0.13	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	111.86	11.25	1.54	2.21	1.54	1.54	3.31	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.07	2.00	0.00	0.67	1.00	1.34	0.33	0.00
aorta, adult, pool1	10052-101G7	36.48	10.79	0.98	0.39	0.78	0.00	0.59	0.39
appendix, adult	10189-103D9	61.71	11.26	1.16	0.00	0.00	0.00	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	5.50	1.03	1.38	0.69	0.34	1.38	0.34
artery, adult	10190-103E1	47.55	5.43	5.43	0.00	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	22.60	3.04	0.14	0.72	0.29	0.43	0.14	0.14
b cell line:RPMI1788	10427-106D4	34.50	4.16	0.45	0.74	0.30	0.30	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.99	2.77	0.28	0.00	0.00	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.60	2.48	0.30	0.40	0.00	0.20	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	5.69	2.01	0.00	0.33	0.00	0.33	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.80	1.12	0.56	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	33.79	6.08	0.43	0.11	0.11	0.11	0.00	0.43
blood, adult, pool1	10053-101G8	28.79	11.07	0.00	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	115.61	19.70	0.00	0.00	0.00	0.86	1.71	0.00
bone marrow, adult	10192-103E3	22.27	3.37	3.37	0.00	0.00	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	116.86	29.73	3.08	1.03	1.03	2.05	2.05	3.08
brain, adult, pool1	10012-101C3	154.34	36.41	1.67	2.34	2.56	1.00	1.11	2.45
brain, fetal, pool1	10085-102B4	48.09	10.69	0.00	2.67	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	22.13	4.63	0.33	0.33	0.00	0.00	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.48	2.87	0.12	0.25	0.00	0.00	0.00	0.25
breast, adult, donor1	10080-102A8	95.33	10.10	1.26	0.63	0.63	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.61	1.02	0.51	0.13	0.25	0.13	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	32.78	8.97	0.31	0.31	0.62	1.55	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.17	6.22	1.38	0.46	0.69	0.23	0.92	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.89	1.21	0.24	0.24	0.24	0.00	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	3.76	3.76	0.00	0.00	0.94	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	88.71	13.13	0.33	0.11	0.88	0.11	0.88	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	0.32	0.32	0.32	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.99	0.80	0.27	0.27	0.00	0.27	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	164.64	40.30	6.91	0.00	3.45	1.15	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	130.01	32.13	3.01	1.67	3.01	0.50	1.00	0.84
caudate nucleus, adult, donor10258	10379-105H1	58.84	12.23	0.00	1.53	0.76	0.76	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	66.65	18.31	1.10	0.73	1.10	1.83	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	104.88	14.57	2.91	0.00	2.91	0.00	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	130.88	39.71	3.63	0.85	2.14	0.85	1.07	1.71
cerebellum, adult, pool1	10083-102B2	47.95	13.11	1.38	0.34	0.69	0.34	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	42.34	25.74	1.66	1.66	0.83	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	60.26	13.11	1.76	1.26	0.50	1.26	0.76	1.51
cerebrospinal fluid, donor2	10294-104G6	121.33	16.08	2.19	0.73	0.73	2.19	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	3.31	0.00	0.00	0.14	0.14	0.00	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	5.97	1.33	0.00	0.17	0.00	0.17	0.00	0.00
cervix, adult, pool1	10013-101C4	37.06	7.14	0.21	0.63	0.31	0.00	0.21	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.98	1.39	0.14	0.14	0.00	0.42	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	82.29	5.23	0.00	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	2.98	0.75	0.12	0.37	0.12	0.12	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	1.97	0.00	0.00	0.00	0.00	0.00	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	1.42	0.24	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	3.70	0.28	0.00	0.00	0.57	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	3.48	0.70	0.10	0.00	0.00	0.20	0.00	0.20
chorionic membrane cells, donor3	12240-129G8	4.40	2.20	0.00	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	0.00	0.00	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.90	4.42	0.19	0.38	0.38	0.19	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.50	2.32	0.21	0.00	0.21	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.80	1.03	0.00	0.00	0.00	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.87	2.42	0.48	0.00	0.24	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.49	2.24	0.81	0.00	0.20	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	31.80	2.65	0.00	1.77	0.59	0.88	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	23.20	2.87	0.00	0.26	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.49	3.66	2.06	1.37	0.46	0.46	1.60	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.15	1.74	0.17	0.17	0.52	0.35	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	14.83	2.75	0.37	0.55	0.18	0.00	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	33.83	3.80	0.00	0.38	0.38	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	16.66	8.33	1.19	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	55.11	13.87	0.35	0.94	0.35	0.94	0.24	2.23
colon, fetal, donor1	10070-101I7	24.72	1.24	0.62	0.00	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	256.68	32.08	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	137.25	27.20	1.27	4.25	0.85	2.12	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	78.64	12.23	0.91	2.57	0.60	1.66	0.45	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	82.07	16.22	1.41	1.69	0.71	1.97	0.71	0.28
corpus callosum, adult, pool1	10042-101F6	717.44	128.69	6.52	3.32	3.54	6.30	7.30	3.32
cruciate ligament, donor2	10295-104G7	42.95	10.54	0.00	0.00	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	24.08	4.01	0.80	0.80	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	192.23	36.96	6.72	3.36	5.52	2.64	2.16	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.02	2.30	1.15	0.23	0.23	0.23	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	8.72	2.05	0.00	0.26	0.00	0.26	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	3.61	0.00	0.00	0.72	0.00	0.00	0.24	0.00
ductus deferens, adult	10196-103E7	54.32	16.94	1.99	1.99	0.00	2.49	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	7.20	1.44	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.05	10.30	2.94	0.74	0.74	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	75.40	15.20	0.83	0.17	0.58	0.50	0.17	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.44	2.00	0.22	0.89	0.00	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	15.76	1.58	0.43	0.14	0.29	0.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	86.94	7.40	1.23	0.00	0.62	1.85	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	64.78	6.36	1.51	1.51	0.61	1.82	0.30	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	77.50	5.87	0.93	0.62	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	97.20	14.45	2.63	0.00	1.31	5.25	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	141.45	23.13	1.01	2.68	0.67	2.35	2.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.25	1.27	0.18	0.54	0.36	0.18	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4.66	1.29	0.96	0.32	0.48	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	17.23	3.00	0.11	0.44	0.00	0.11	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.70	2.64	0.11	0.33	0.11	0.00	0.00	0.00
epididymis, adult	10197-103E8	33.91	8.79	1.05	0.42	0.63	1.26	0.00	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	13.31	0.00	0.00	0.53	0.35	0.18	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3.93	1.70	0.00	0.13	0.26	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	4.72	2.17	0.30	0.10	0.10	0.00	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.82	1.90	0.22	0.00	0.11	0.11	0.00	0.11
esophagus, adult, pool1	10015-101C6	27.71	5.52	1.06	0.64	0.42	0.00	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.70	0.50	0.25	0.13	0.13	0.25	0.38	0.25
eye - muscle inferior rectus, donor1	10272-104E2	99.00	9.66	2.41	0.00	9.66	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	0.00	0.00	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	63.99	2.98	0.00	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	9.17	0.00	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	85.99	30.61	0.00	0.00	0.00	2.91	0.00	1.46
eye, fetal, donor1	10054-101G9	40.68	15.00	0.76	0.51	1.02	0.76	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	20.26	3.08	0.26	0.64	0.26	0.38	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.56	3.32	0.47	0.00	0.24	0.47	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	186.24	36.69	1.22	1.22	1.41	2.16	1.41	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	3.90	0.60	0.30	0.00	0.30	0.30	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.20	3.66	0.27	0.27	0.37	0.18	0.18	0.46
gall bladder, adult	10198-103E9	51.43	9.42	2.41	0.00	1.21	1.21	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	18.25	5.37	0.00	0.54	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	60.51	17.93	0.37	2.61	1.12	0.00	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	5.70	0.42	0.00	0.00	0.63	0.00	0.84	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	34.43	3.87	0.39	0.00	0.58	0.39	1.35	0.97
gastric cancer cell line:AZ521	10549-107H9	9.67	2.13	0.16	0.00	0.00	0.16	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	7.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	88.64	5.71	3.88	1.60	2.06	0.46	1.83	1.14
giant cell carcinoma cell line:LU65	10487-107B1	0.92	0.00	0.00	0.00	0.00	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	22.39	0.98	0.14	0.42	0.00	0.56	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.99	2.00	0.25	0.00	0.00	0.00	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.03	1.06	0.00	0.00	0.00	0.00	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.83	1.54	0.00	0.00	0.28	0.00	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	64.46	8.61	0.88	1.32	0.77	1.21	0.55	0.55
glioma cell line:GI-1	10413-106B8	43.35	8.49	0.88	0.59	0.88	0.29	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	208.47	62.69	3.64	4.37	4.37	2.92	5.10	4.37
globus pallidus, adult, donor10252	10161-103A8	686.39	149.39	14.65	10.74	12.20	7.32	3.17	6.35
globus pallidus, adult, donor10258	10367-105F7	273.84	82.15	6.85	4.11	10.95	5.48	13.69	2.74
globus pallidus, newborn, donor10223	10364-105F4	149.75	19.72	4.26	5.33	2.13	0.53	1.07	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.36	5.12	0.32	0.32	0.96	0.00	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	10.56	1.38	0.46	0.00	0.00	0.00	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	9.60	1.37	0.00	0.00	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	0.64	0.00	0.00	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	1.37	0.69	0.00	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	78.35	18.76	0.00	1.10	0.00	1.10	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	18.96	1.44	0.29	1.72	0.00	0.00	0.57	0.00
heart - mitral valve, adult	10205-103F7	69.66	16.14	1.49	0.90	1.20	1.20	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	82.36	13.60	1.31	1.31	2.61	0.52	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	142.38	23.31	0.83	6.66	0.00	1.67	0.83	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	54.48	10.61	1.22	0.41	1.43	1.43	1.02	0.41
heart, adult, diseased, donor1	10051-101G6	71.54	18.74	2.98	0.43	2.13	0.43	1.28	0.43
heart, adult, pool1	10016-101C7	98.43	15.64	1.15	1.15	0.00	1.84	0.00	0.92
heart, fetal, pool1	10046-101G1	188.62	36.76	1.13	1.44	1.23	1.13	1.13	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.73	3.39	0.00	0.31	0.00	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	61.84	3.57	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	51.71	8.18	1.55	0.55	0.44	0.77	0.66	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	50.98	8.37	2.18	0.49	0.73	0.85	0.49	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	60.13	8.59	1.31	0.51	0.61	1.31	0.40	0.40
hepatoma cell line:Li-7	10484-107A7	36.03	4.23	0.33	1.11	0.44	1.11	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.04	1.61	0.00	0.10	0.00	0.10	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	114.51	20.82	2.84	0.95	1.89	0.00	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	320.44	74.29	8.37	5.10	6.12	3.88	2.45	3.06
hippocampus, adult, donor10258	10374-105G5	62.24	16.43	1.49	0.00	0.00	1.00	4.98	1.00
hippocampus, newborn, donor10223	10363-105F3	45.12	14.10	0.70	0.35	0.35	0.70	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	5.49	0.61	1.22	0.00	0.00	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.85	0.20	0.39	0.00	0.20	0.98	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.86	0.25	0.00	0.00	0.00	0.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	26.50	1.13	0.00	1.69	0.00	1.13	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.08	2.32	3.87	0.77	1.55	0.26	0.77	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.67	1.14	1.52	0.00	0.38	0.00	1.52	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	38.25	3.80	1.17	1.17	0.88	1.17	0.88	6.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.78	4.09	1.94	0.22	2.37	0.65	0.22	6.68
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.53	3.34	0.42	1.25	1.25	1.67	0.00	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	31.97	2.37	0.47	0.95	0.71	0.24	0.47	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	42.59	3.54	0.64	1.77	2.25	0.80	0.64	3.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	31.65	4.71	0.67	0.67	0.00	0.67	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.04	0.47	0.47	0.00	0.31	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	0.49	0.49	0.49	0.00	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.63	1.34	1.34	0.38	1.34	0.76	0.00	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.01	1.31	0.87	0.44	0.87	0.87	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	28.99	3.00	0.50	0.50	0.50	1.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	32.97	0.75	1.13	0.19	1.13	0.19	0.19	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	22.74	3.64	0.91	1.36	0.45	0.45	0.45	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.69	3.76	0.63	0.94	0.31	1.25	0.31	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.27	4.74	0.82	0.65	0.65	0.65	0.82	2.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	21.48	3.48	0.87	0.00	0.87	0.00	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.31	3.89	0.60	1.79	0.60	1.20	0.60	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.24	0.55	0.18	0.00	0.37	0.37	0.55	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	9.98	0.86	0.57	0.00	0.29	0.29	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	4.90	0.00	0.00	0.00	1.22	0.41	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.24	2.11	3.17	0.70	1.41	0.35	0.00	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.61	0.95	0.32	0.00	0.95	0.63	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	21.18	2.42	2.42	0.61	1.21	0.61	0.91	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	3.10	0.00	0.00	1.55	0.52	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	3.98	0.66	0.00	0.00	0.66	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.09	1.54	0.00	1.03	0.77	0.00	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.29	2.30	2.05	0.77	0.51	0.26	1.28	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	34.08	5.30	2.27	1.51	0.00	3.03	0.76	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	17.81	1.68	0.34	0.67	0.34	1.01	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.66	0.48	0.24	0.00	0.00	0.48	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.91	0.45	0.45	0.00	0.00	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.34	0.00	0.00	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	30.26	2.44	1.22	0.31	0.92	0.31	0.61	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	6.51	0.00	0.00	6.51	0.00	6.51	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.83	1.65	0.33	0.99	0.99	0.66	0.33	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	2.74	0.55	0.55	3.28	0.55	0.00	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	33.66	2.17	0.00	0.72	0.00	0.36	0.72	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.42	1.07	0.36	0.71	2.14	0.00	0.00	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	4.77	1.19	0.00	0.00	2.39	0.00	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	44.83	4.20	1.63	0.81	1.22	0.27	0.41	7.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	21.82	3.23	0.54	0.81	0.00	0.54	0.00	1.62
immature langerhans cells, donor1	11904-125F5	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	2.38	2.38	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	225.13	46.18	1.70	1.51	0.85	1.51	2.27	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	5.85	1.30	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	125.76	21.53	1.20	2.60	2.70	2.20	0.70	2.00
kidney, fetal, pool1	10045-101F9	153.28	25.32	0.92	1.13	0.92	0.64	1.13	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	120.01	14.20	0.71	1.42	0.99	1.28	0.28	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.44	4.15	0.97	0.55	0.69	0.69	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.73	0.37	0.00	0.18	0.00	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	37.05	6.54	1.63	0.54	0.54	1.09	2.18	0.00
left ventricle, adult, donor1	10078-102A6	45.00	9.10	2.02	0.51	1.01	0.51	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	3.01	0.55	0.00	0.27	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	10.78	2.87	1.08	0.72	0.36	0.72	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	15.76	1.63	0.54	0.54	1.63	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	11.90	4.61	0.49	0.24	0.73	0.73	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	1.05	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.07	1.53	0.35	0.00	0.24	0.00	0.24	0.24
liposarcoma cell line:KMLS-1	10782-110G8	36.71	8.12	1.09	0.00	0.94	0.47	0.47	1.09
liposarcoma cell line:SW 872	10726-110A6	36.19	5.85	0.24	0.24	0.12	0.24	0.61	0.00
liver, adult, pool1	10018-101C9	130.78	13.61	2.43	3.24	6.32	1.46	1.62	7.62
liver, fetal, pool1	10086-102B5	30.10	3.76	0.00	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	320.67	55.41	5.40	5.40	4.67	2.48	2.62	2.19
locus coeruleus, adult, donor10252	10165-103B3	220.54	52.78	4.80	3.32	4.43	2.40	3.14	2.03
locus coeruleus, adult, donor10258	10375-105G6	110.32	22.85	5.36	0.56	3.95	1.13	7.34	2.82
locus coeruleus, newborn, donor10223	10362-105F2	59.73	21.87	7.99	2.10	4.63	2.94	0.42	6.31
lung adenocarcinoma cell line:A549	10499-107C4	11.21	2.77	0.14	0.14	0.00	0.14	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	4.14	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	135.90	8.57	0.92	1.05	1.58	0.26	1.19	0.13
lung, adult, pool1	10019-101D1	55.99	8.62	0.47	0.59	0.95	0.71	0.12	1.42
lung, fetal, donor1	10068-101I5	83.34	19.12	1.14	0.00	1.14	0.00	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	65.07	11.91	2.29	1.37	1.37	0.46	0.92	1.83
lymph node, adult, donor1	10077-102A5	47.81	7.10	0.47	0.47	0.00	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	141.81	21.70	1.10	3.07	1.32	1.97	1.10	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.75	0.45	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	7.65	4.25	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	122.54	13.76	0.89	0.00	0.00	2.66	0.00	0.00
mature adipocyte, donor2	12232-129F9	128.87	21.79	2.49	2.08	1.25	2.28	0.21	2.08
mature adipocyte, donor3	12233-129G1	100.99	21.81	1.19	0.71	0.95	0.71	0.00	2.61
mature adipocyte, donor4	12234-129G2	75.02	11.84	0.79	1.05	0.79	0.00	0.26	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	75.29	16.68	0.48	0.00	0.24	0.48	0.48	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	59.79	20.30	0.00	1.13	1.13	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	208.18	48.92	4.23	1.29	5.15	1.84	1.66	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	49.56	12.71	1.91	1.59	0.64	0.64	1.27	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	17.06	11.52	2.56	0.85	1.28	0.43	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	132.30	32.57	12.99	0.51	9.62	0.34	14.01	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	248.09	68.12	6.37	2.97	3.40	1.70	1.91	2.55
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	5.78	3.85	0.00	0.00	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	0.00	0.00	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.43	10.77	0.00	0.36	0.00	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	107.08	17.52	0.00	2.60	3.24	1.95	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	216.11	53.25	4.95	3.10	5.88	1.39	1.39	1.70
medulla oblongata, adult, pool1	10038-101F2	315.00	65.71	2.53	1.22	1.47	1.80	2.69	0.73
medulla oblongata, newborn, donor10223	10361-105F1	112.49	22.22	2.08	4.17	0.69	3.12	2.43	1.74
medulloblastoma cell line:D283 Med	10838-111E1	16.38	0.44	1.77	0.22	0.89	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	23.72	2.69	0.00	0.24	0.12	0.00	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	1.15	0.43	0.14	0.00	0.29	0.00	0.00	0.14
melanoma cell line:G-361	10465-106H6	18.73	2.17	1.09	0.81	1.09	0.81	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	17.55	3.80	0.72	0.72	0.36	0.36	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	26.43	2.64	1.76	0.00	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	33.44	8.30	1.81	0.78	1.56	0.78	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.29	1.84	0.00	0.15	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.54	0.36	0.36	0.55	0.00	0.00	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	6.21	0.83	0.41	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.23	6.32	0.42	0.14	0.56	0.14	0.98	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.51	1.93	0.19	0.19	0.00	0.00	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	6.94	0.00	0.00	0.69	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.01	3.09	0.69	0.17	0.17	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.87	2.53	0.35	0.12	0.00	0.46	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.84	1.19	0.27	0.00	0.00	0.13	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.91	2.57	0.27	0.14	0.00	0.68	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.97	1.71	0.43	0.43	0.00	0.14	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	4.28	1.32	0.33	0.33	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	5.81	1.38	0.00	0.28	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.96	5.59	0.35	0.00	0.35	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.74	2.25	0.20	0.00	0.00	0.20	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.55	3.24	1.08	0.00	0.72	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.24	1.24	0.00	0.10	0.00	0.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.36	4.56	0.00	0.00	0.23	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.23	1.26	1.26	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	5.68	2.09	0.30	0.15	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.44	0.88	0.44	0.09	0.09	0.18	0.53	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.84	2.21	0.00	0.00	0.37	0.00	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.46	4.86	0.29	0.29	0.86	0.00	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.89	5.89	2.11	1.26	1.26	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	3.65	0.91	0.00	0.00	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.60	1.79	0.26	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.50	2.36	0.00	0.26	0.00	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.24	2.16	0.31	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.18	0.71	0.47	0.00	0.00	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.43	2.37	0.00	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	0.79	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.10	0.93	0.00	0.46	0.00	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.79	1.73	0.29	0.00	0.87	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.47	1.34	0.00	0.22	0.00	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.45	1.44	0.00	0.00	0.00	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	14.67	2.20	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	2.01	0.00	0.00	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	1.64	0.00	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	1.29	0.00	0.00	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.15	1.62	0.00	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	2.45	0.82	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.94	1.55	0.00	0.00	0.00	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	0.00	0.00	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	0.59	0.00	0.00	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	6.09	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	1.90	0.00	1.27	0.00	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.01	4.48	0.69	1.03	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	4.30	2.15	0.00	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	3.44	0.00	0.00	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.71	4.07	0.41	0.41	0.00	0.41	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	5.56	0.79	0.00	0.00	0.79	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	36.55	1.18	0.59	2.36	0.59	1.77	2.36	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.18	3.12	0.31	1.87	0.94	0.62	1.56	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	1.34	1.34	0.00	2.67	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	5.91	1.18	1.18	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	2.57	2.57	2.57	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	14.46	2.75	0.00	0.69	0.00	0.69	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	18.31	0.99	0.00	0.00	0.99	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	0.00	0.00	0.00	0.00	0.00	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	1.91	0.00	0.00	0.64	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.49	1.21	0.00	0.81	0.40	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	2.53	0.00	1.27	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	3.64	1.21	0.00	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	2.47	0.00	0.82	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.94	1.19	0.00	0.79	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	1.62	0.00	0.32	0.00	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	2.04	1.02	1.02	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.95	10.83	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	10.63	0.71	0.00	0.00	0.24	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.57	1.62	0.00	0.23	0.00	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.19	1.23	0.00	0.21	0.10	0.10	0.62	0.00
mesothelioma cell line:Mero-25	10850-111F4	3.40	0.23	0.00	0.23	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	23.47	5.87	0.24	0.00	0.49	0.98	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	11.07	4.21	0.00	0.00	0.44	1.33	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	9.72	1.31	0.53	0.00	0.26	0.00	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	9.19	2.21	0.17	0.00	0.00	0.34	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.04	0.41	0.00	0.21	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	10.93	2.32	0.33	0.33	0.17	0.50	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	10.14	0.72	0.00	0.36	0.54	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	9.74	2.73	0.17	0.00	0.00	0.85	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	31.55	14.76	1.27	0.25	0.51	1.02	1.27	0.00
mesothelioma cell line:No36	10857-111G2	1.63	0.65	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	9.21	1.90	0.00	0.54	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	4.03	2.30	0.19	0.00	0.19	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.40	1.34	0.24	0.12	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	2.33	0.18	0.00	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.18	3.92	1.96	2.29	1.96	0.98	1.31	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.44	2.76	0.64	0.64	0.42	0.21	1.06	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.13	3.46	0.23	0.46	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	68.31	12.56	0.38	0.38	0.95	0.76	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.94	1.85	0.00	0.37	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	3.36	0.20	0.00	0.20	0.00	0.00	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.19	5.58	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.90	6.08	0.39	0.20	0.59	0.98	0.39	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.90	1.00	0.00	0.33	0.11	0.11	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.24	1.03	0.00	0.15	0.00	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	10.49	4.97	0.00	0.00	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	39.80	5.75	0.23	0.23	0.00	0.23	0.00	0.92
neuroblastoma cell line:NB-1	10539-107G8	28.25	9.54	0.37	0.19	0.19	0.37	0.56	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	11.18	0.63	0.00	0.42	0.21	0.42	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	37.83	4.29	0.37	0.19	0.19	0.19	1.30	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.16	0.71	0.71	0.47	0.95	0.47	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.84	1.74	0.32	0.00	0.48	0.32	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	3.42	0.00	0.00	0.00	0.00	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.09	1.27	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	16.77	2.66	0.00	0.00	0.00	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	803.24	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	67.48	6.93	0.85	0.34	0.00	0.17	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.02	6.40	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.79	1.28	0.00	0.00	0.96	0.64	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.74	4.99	1.31	1.31	0.79	0.53	1.31	0.26
nucleus accumbens, adult, pool1	10037-101F1	264.06	52.03	2.53	1.31	1.12	0.84	2.16	1.12
occipital cortex - adult, donor10196	10172-103C1	146.29	30.91	6.18	0.00	6.18	2.06	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	338.67	86.95	9.39	6.44	6.44	4.03	2.15	3.22
occipital cortex, newborn, donor10223	10355-105E4	22.56	18.93	0.73	0.36	0.73	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	162.42	32.80	2.62	4.46	8.92	2.10	3.41	1.84
occipital lobe, fetal, donor1	10073-102A1	42.91	20.17	1.72	0.86	1.72	0.86	0.86	1.29
occipital pole, adult, pool1	10036-101E9	143.81	28.07	0.71	0.55	0.63	0.79	1.34	0.39
olfactory region, adult	10195-103E6	151.50	33.63	5.35	2.48	3.82	0.96	2.10	0.96
optic nerve, donor1	10277-104E7	644.34	102.05	10.01	24.01	16.01	8.00	2.00	26.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.59	6.38	0.23	0.34	0.11	0.34	0.00	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.36	0.00	0.00	0.55	0.00	0.14	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.45	1.35	0.17	0.34	0.51	0.00	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	4.85	0.35	0.12	0.00	0.12	0.00	0.35	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	10.88	1.76	0.00	0.00	0.29	0.00	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	227.04	17.75	0.93	0.00	0.00	0.93	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	14.63	6.15	0.21	0.42	0.21	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	31.27	4.11	0.26	0.00	0.35	0.35	0.09	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	47.30	5.13	0.18	0.37	0.73	0.55	0.92	0.18
pancreas, adult, donor1	10049-101G4	30.10	7.53	0.00	0.00	1.88	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.78	2.73	0.34	0.17	0.68	0.17	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.27	1.16	0.33	0.00	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	180.02	32.31	1.01	1.01	0.82	1.74	1.83	0.64
parietal cortex, adult, donor10258	10373-105G4	53.58	19.82	0.73	0.00	1.47	0.00	5.87	0.00
parietal lobe - adult, donor10196	10171-103B9	107.22	32.92	3.76	0.94	5.64	0.00	3.76	2.82
parietal lobe, adult, donor10252	10157-103A4	182.42	45.61	3.71	3.71	3.42	2.00	1.71	2.57
parietal lobe, adult, pool1	10034-101E7	222.77	44.68	2.20	1.23	0.62	1.15	1.85	1.41
parietal lobe, fetal, donor1	10072-101I9	33.94	17.46	0.00	0.97	2.91	0.00	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	20.56	16.08	0.75	1.12	0.75	0.37	0.00	0.00
parotid gland, adult	10199-103F1	43.78	16.65	1.85	0.00	2.47	0.62	0.00	0.00
penis, adult	10200-103F2	38.67	4.83	2.15	0.00	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1.12	0.00	0.00	0.19	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	4.37	0.29	0.15	0.00	0.44	0.15	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	68.37	51.60	1.29	2.58	1.94	0.65	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	130.88	100.68	1.78	2.37	2.96	0.59	0.59	3.55
pineal gland, adult, donor10258	10377-105G8	50.17	50.79	0.00	1.25	3.14	1.25	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	65.77	44.52	1.01	2.02	2.02	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	118.31	64.11	0.52	1.04	1.04	1.04	0.52	2.08
pituitary gland, adult, donor10258	10378-105G9	40.86	16.17	0.00	0.85	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	19.46	2.26	0.43	0.22	0.00	0.22	0.32	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	16.02	3.71	0.13	0.26	0.66	0.40	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	49.65	15.56	0.31	1.25	0.62	0.31	0.47	0.78
pons, adult, pool1	10033-101E6	211.12	43.29	1.29	1.72	1.46	1.03	1.29	0.34
postcentral gyrus, adult, pool1	10032-101E5	164.33	33.56	1.57	1.48	1.22	1.31	1.83	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	119.21	6.27	0.00	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.44	4.52	0.87	0.87	0.44	1.75	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	136.49	15.61	0.73	3.99	1.27	3.27	2.00	0.91
prostate, adult, pool1	10022-101D4	40.36	5.80	0.36	0.45	0.36	0.27	0.09	0.27
putamen, adult, donor10196	10176-103C5	165.95	43.67	4.25	2.12	4.72	2.60	2.12	0.94
putamen, adult, donor10252	10152-102I8	137.25	27.45	1.96	5.88	1.96	5.88	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	33.88	6.56	2.19	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	140.62	21.99	0.72	0.48	2.66	0.97	4.83	1.21
putamen, newborn, donor10223	10365-105F5	59.97	29.24	3.75	0.75	4.50	0.75	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	2.04	0.29	0.00	0.58	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	23.65	9.74	0.00	1.39	1.39	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	96.25	16.11	1.91	1.70	1.91	2.33	1.91	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	105.21	6.21	2.07	1.66	2.90	1.24	2.07	0.41
retina, adult, pool1	10030-101E3	107.95	30.52	1.59	0.89	0.80	0.50	0.60	0.89
retinoblastoma cell line:Y79	10475-106I7	15.85	1.56	0.00	0.78	0.52	0.00	0.26	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.31	0.98	0.12	0.00	0.00	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	43.87	1.97	0.28	1.41	0.00	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.21	11.37	0.76	1.52	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	37.55	9.06	1.78	0.00	0.81	0.00	0.65	0.65
salivary acinar cells, donor2	11772-123I8	67.05	13.08	3.03	0.55	1.65	0.83	1.38	0.69
salivary acinar cells, donor3	11773-123I9	207.88	29.79	0.66	0.00	0.00	0.00	2.65	0.66
salivary gland, adult, pool1	10093-102C3	32.60	13.73	0.00	1.72	0.00	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.11	4.38	0.51	0.67	0.25	0.42	0.17	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.39	5.17	0.24	0.82	0.00	0.12	0.35	0.24
seminal vesicle, adult	10201-103F3	56.08	14.81	4.23	1.06	1.06	2.12	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.32	1.94	0.24	0.24	0.49	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.04	1.51	0.00	0.25	0.25	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	7.02	0.00	2.01	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.73	1.07	0.27	0.40	0.67	0.81	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	17.02	2.21	0.00	0.44	0.11	0.44	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.03	8.13	0.52	0.52	0.39	0.39	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	205.71	24.12	3.55	2.13	1.42	1.42	0.71	2.13
skeletal muscle, adult, pool1	10023-101D5	69.56	7.20	0.36	1.32	0.96	0.72	0.24	1.92
skeletal muscle, fetal, donor1	10066-101I3	8.04	1.01	0.00	0.00	1.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	21.46	3.16	0.00	0.63	2.52	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.68	5.00	0.00	0.67	0.00	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	45.70	11.66	0.63	1.26	0.95	0.32	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.82	0.77	0.39	0.39	0.19	0.39	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	60.49	14.67	0.82	1.15	0.16	0.99	0.99	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	44.72	4.02	1.13	0.32	0.32	0.16	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.56	17.87	0.87	0.65	0.65	0.65	1.31	0.44
small intestine, adult, pool1	10024-101D6	43.48	12.06	0.60	0.96	0.72	0.36	0.36	0.72
small intestine, fetal, donor1	10064-101I1	11.30	2.70	0.74	0.49	0.00	0.25	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	60.01	16.41	2.56	3.08	2.05	3.59	2.56	1.54
smooth muscle, adult, pool1	10048-101G3	18.35	4.91	1.03	0.26	0.26	0.26	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	45.30	30.55	0.54	0.00	0.54	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	191.32	51.85	8.72	2.06	7.11	0.92	5.28	2.98
spinal cord, adult, donor10252	10159-103A6	198.32	57.96	0.79	3.94	4.34	1.18	1.18	2.76
spinal cord, adult, donor10258	10369-105F9	44.97	22.14	4.84	1.38	0.69	0.69	4.15	0.00
spinal cord, fetal, donor1	10056-101H2	164.66	33.54	4.27	4.88	4.88	3.66	1.83	2.44
spinal cord, newborn, donor10223	10359-105E8	93.22	28.93	6.43	1.84	5.05	1.38	1.84	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	15.68	4.33	0.15	0.15	0.30	0.30	0.00	0.00
spleen, adult, pool1	10025-101D7	67.18	13.55	1.10	0.77	1.76	0.77	0.55	1.54
spleen, fetal, pool1	10044-101F8	42.99	9.93	0.48	0.08	0.40	0.00	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.00	0.52	0.00	0.10	0.10	0.21	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	6.65	0.76	0.00	0.19	0.00	0.19	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.06	4.89	0.35	0.35	0.00	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.89	5.08	0.00	0.39	0.00	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.67	6.19	0.23	1.13	0.00	0.68	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.47	1.69	0.85	0.00	0.00	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.19	5.08	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	167.67	12.82	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	41.02	19.37	2.85	0.00	1.14	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	271.37	108.55	217.10	379.92	0.00
substantia nigra, adult, donor10252	10158-103A5	284.14	100.11	9.55	10.39	3.74	7.69	2.28	2.70
substantia nigra, adult, donor10258	10371-105G2	91.04	26.38	1.03	0.00	1.55	0.00	3.62	1.03
substantia nigra, newborn, donor10223	10358-105E7	137.08	43.81	2.12	4.24	2.83	4.24	0.71	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	16.51	3.67	0.00	0.46	0.00	0.23	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	187.09	35.94	2.20	1.36	0.76	1.36	1.61	1.27
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	52.00	25.64	0.71	2.14	3.56	0.71	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	41.76	21.98	3.52	0.00	0.88	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	13.96	3.49	0.70	0.00	0.00	0.00	0.70	0.00
tenocyte, donor2	11765-123I1	2.67	0.76	0.38	0.00	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	5.19	1.48	0.37	0.37	0.37	0.00	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.24	1.19	0.51	0.17	0.85	0.68	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.34	0.46	0.31	0.15	0.46	0.15	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	11.62	0.62	0.00	0.00	0.31	0.15	0.31	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.30	0.38	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.83	0.38	0.00	0.00	0.38	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3.27	0.44	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.01	0.33	0.65	0.98	1.95	0.00	0.33	0.33
testis, adult, pool1	10026-101D8	24.80	3.44	0.21	0.43	0.86	0.00	0.11	1.83
testis, adult, pool2	10096-102C6	19.85	3.16	0.90	0.00	0.45	0.45	1.80	0.00
thalamus - adult, donor10196	10168-103B6	240.67	68.45	7.73	6.62	3.31	4.42	4.42	2.21
thalamus, adult, donor10252	10154-103A1	445.72	110.18	8.60	6.41	8.44	7.03	3.91	4.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	89.30	29.25	3.08	1.54	6.16	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	105.40	22.56	4.28	2.31	2.31	1.48	3.46	1.15
thalamus, newborn, donor10223	10366-105F6	18.41	14.96	2.30	1.15	2.30	0.58	0.00	0.00
throat, adult	10209-103G2	36.70	5.74	1.50	0.00	1.25	0.50	0.25	1.25
throat, fetal, donor1	10061-101H7	21.33	2.44	1.83	0.61	0.00	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	47.50	6.96	0.20	0.40	0.79	0.40	0.20	0.60
thymus, adult, pool1	10027-101D9	26.84	4.27	0.40	0.10	0.60	0.00	0.10	0.60
thymus, fetal, pool1	10043-101F7	66.50	16.73	1.35	0.31	0.10	0.31	0.00	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.05	5.45	0.53	0.27	0.40	0.93	0.66	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	21.51	4.19	0.28	0.56	0.28	0.00	0.70	0.14
thyroid, adult, pool1	10028-101E1	59.44	6.07	0.47	0.56	0.84	0.56	0.65	1.21
thyroid, fetal, donor1	10060-101H6	30.32	3.16	0.79	0.79	0.79	0.00	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	12.32	0.00	6.16	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	26.28	3.72	2.09	0.23	0.47	0.23	0.47	0.93
tongue, fetal, donor1	10059-101H5	11.82	1.97	0.00	0.00	1.58	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	48.89	10.82	0.20	0.40	0.10	0.30	0.20	0.10
trachea, adult, pool1	10029-101E2	48.59	10.39	0.41	0.41	0.74	0.16	0.25	1.06
trachea, fetal, donor1	10058-101H4	23.47	4.23	0.38	0.00	0.00	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.98	1.42	0.35	0.71	0.00	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	47.82	6.38	0.41	0.61	0.51	0.10	0.20	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	42.15	5.17	0.94	2.04	0.78	1.57	0.78	0.78
tridermal teratoma cell line:HGRT	10694-109G1	123.66	20.93	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.01	5.93	0.42	0.08	0.34	0.17	0.68	0.17
umbilical cord, fetal, donor1	10057-101H3	14.61	4.17	2.09	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	30.71	4.61	0.68	0.17	0.17	0.00	0.17	0.51
uterus, fetal, donor1	10055-101H1	14.85	3.07	1.02	0.51	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	73.67	7.11	0.65	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	36.39	8.77	2.63	0.66	0.88	0.88	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	20.29	3.74	0.00	0.80	0.53	0.80	0.53	0.00